Global and China Diabetes Treatment Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diabetes Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Insulin
1.2.3 Oral Hypoglycaemic Drugs
1.2.4 Non-Insulin Injectable Drugs
1.2.5 Others
1.3 Market by Application
1.3.1 Global Diabetes Treatment Market Share by Application: 2020 VS 2026
1.3.2 Hospital
1.3.3 Personal Use
1.3.4 Clinic
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Diabetes Treatment Market Perspective (2015-2026)
2.2 Global Diabetes Treatment Growth Trends by Regions
2.2.1 Diabetes Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Diabetes Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Diabetes Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Diabetes Treatment Players by Market Size
3.1.1 Global Top Diabetes Treatment Players by Revenue (2015-2020)
3.1.2 Global Diabetes Treatment Revenue Market Share by Players (2015-2020)
3.2 Global Diabetes Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Diabetes Treatment Revenue
3.4 Global Diabetes Treatment Market Concentration Ratio
3.4.1 Global Diabetes Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diabetes Treatment Revenue in 2019
3.5 Key Players Diabetes Treatment Area Served
3.6 Key Players Diabetes Treatment Product Solution and Service
3.7 Date of Enter into Diabetes Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Diabetes Treatment Breakdown Data by Type (2015-2026)
4.1 Global Diabetes Treatment Historic Market Size by Type (2015-2020)
4.2 Global Diabetes Treatment Forecasted Market Size by Type (2021-2026)
5 Diabetes Treatment Breakdown Data by Application (2015-2026)
5.1 Global Diabetes Treatment Historic Market Size by Application (2015-2020)
5.2 Global Diabetes Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Diabetes Treatment Market Size (2015-2026)
6.2 North America Diabetes Treatment Market Size by Type (2015-2020)
6.3 North America Diabetes Treatment Market Size by Application (2015-2020)
6.4 North America Diabetes Treatment Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Diabetes Treatment Market Size (2015-2026)
7.2 Europe Diabetes Treatment Market Size by Type (2015-2020)
7.3 Europe Diabetes Treatment Market Size by Application (2015-2020)
7.4 Europe Diabetes Treatment Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Diabetes Treatment Market Size (2015-2026)
8.2 China Diabetes Treatment Market Size by Type (2015-2020)
8.3 China Diabetes Treatment Market Size by Application (2015-2020)
8.4 China Diabetes Treatment Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Diabetes Treatment Market Size (2015-2026)
9.2 Japan Diabetes Treatment Market Size by Type (2015-2020)
9.3 Japan Diabetes Treatment Market Size by Application (2015-2020)
9.4 Japan Diabetes Treatment Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Diabetes Treatment Market Size (2015-2026)
10.2 Southeast Asia Diabetes Treatment Market Size by Type (2015-2020)
10.3 Southeast Asia Diabetes Treatment Market Size by Application (2015-2020)
10.4 Southeast Asia Diabetes Treatment Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Novo Nordisk
11.1.1 Novo Nordisk Company Details
11.1.2 Novo Nordisk Business Overview
11.1.3 Novo Nordisk Diabetes Treatment Introduction
11.1.4 Novo Nordisk Revenue in Diabetes Treatment Business (2015-2020))
11.1.5 Novo Nordisk Recent Development
11.2 Bayer
11.2.1 Bayer Company Details
11.2.2 Bayer Business Overview
11.2.3 Bayer Diabetes Treatment Introduction
11.2.4 Bayer Revenue in Diabetes Treatment Business (2015-2020)
11.2.5 Bayer Recent Development
11.3 Teva Pharmaceuticals
11.3.1 Teva Pharmaceuticals Company Details
11.3.2 Teva Pharmaceuticals Business Overview
11.3.3 Teva Pharmaceuticals Diabetes Treatment Introduction
11.3.4 Teva Pharmaceuticals Revenue in Diabetes Treatment Business (2015-2020)
11.3.5 Teva Pharmaceuticals Recent Development
11.4 Merck&Company
11.4.1 Merck&Company Company Details
11.4.2 Merck&Company Business Overview
11.4.3 Merck&Company Diabetes Treatment Introduction
11.4.4 Merck&Company Revenue in Diabetes Treatment Business (2015-2020)
11.4.5 Merck&Company Recent Development
11.5 Medtronic
11.5.1 Medtronic Company Details
11.5.2 Medtronic Business Overview
11.5.3 Medtronic Diabetes Treatment Introduction
11.5.4 Medtronic Revenue in Diabetes Treatment Business (2015-2020)
11.5.5 Medtronic Recent Development
11.6 Johnson&Johnson
11.6.1 Johnson&Johnson Company Details
11.6.2 Johnson&Johnson Business Overview
11.6.3 Johnson&Johnson Diabetes Treatment Introduction
11.6.4 Johnson&Johnson Revenue in Diabetes Treatment Business (2015-2020)
11.6.5 Johnson&Johnson Recent Development
11.7 Home Diagnostics
11.7.1 Home Diagnostics Company Details
11.7.2 Home Diagnostics Business Overview
11.7.3 Home Diagnostics Diabetes Treatment Introduction
11.7.4 Home Diagnostics Revenue in Diabetes Treatment Business (2015-2020)
11.7.5 Home Diagnostics Recent Development
11.8 Amylin Pharmaceuticals
11.8.1 Amylin Pharmaceuticals Company Details
11.8.2 Amylin Pharmaceuticals Business Overview
11.8.3 Amylin Pharmaceuticals Diabetes Treatment Introduction
11.8.4 Amylin Pharmaceuticals Revenue in Diabetes Treatment Business (2015-2020)
11.8.5 Amylin Pharmaceuticals Recent Development
11.9 Abbott Laboratories
11.9.1 Abbott Laboratories Company Details
11.9.2 Abbott Laboratories Business Overview
11.9.3 Abbott Laboratories Diabetes Treatment Introduction
11.9.4 Abbott Laboratories Revenue in Diabetes Treatment Business (2015-2020)
11.9.5 Abbott Laboratories Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Diabetes Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Insulin
Table 4. Key Players of Oral Hypoglycaemic Drugs
Table 5. Key Players of Non-Insulin Injectable Drugs
Table 6. Key Players of Others
Table 7. Global Diabetes Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Diabetes Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Diabetes Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Diabetes Treatment Market Share by Regions (2015-2020)
Table 11. Global Diabetes Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Diabetes Treatment Market Share by Regions (2021-2026)
Table 13. Diabetes Treatment Market Market Trends
Table 14. Diabetes Treatment Market Drivers
Table 15. Diabetes Treatment Market Challenges
Table 16. Diabetes Treatment Market Restraints
Table 17. Global Diabetes Treatment Revenue by Players (2015-2020) (US$ Million)
Table 18. Global Diabetes Treatment Market Share by Players (2015-2020)
Table 19. Global Top Diabetes Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetes Treatment as of 2019)
Table 20. Global Diabetes Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Diabetes Treatment Product Solution and Service
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Diabetes Treatment Market Size by Type (2015-2020) (US$ Million)
Table 25. Global Diabetes Treatment Market Size Share by Type (2015-2020)
Table 26. Global Diabetes Treatment Revenue Market Share by Type (2021-2026)
Table 27. Global Diabetes Treatment Market Size Share by Application (2015-2020)
Table 28. Global Diabetes Treatment Market Size by Application (2015-2020) (US$ Million)
Table 29. Global Diabetes Treatment Market Size Share by Application (2021-2026)
Table 30. North America Diabetes Treatment Market Size by Type (2015-2020) (US$ Million)
Table 31. North America Diabetes Treatment Market Share by Type (2015-2020)
Table 32. North America Diabetes Treatment Market Size by Application (2015-2020) (US$ Million)
Table 33. North America Diabetes Treatment Market Share by Application (2015-2020)
Table 34. North America Diabetes Treatment Market Size by Country (US$ Million) (2015-2020)
Table 35. North America Diabetes Treatment Market Share by Country (2015-2020)
Table 36. Europe Diabetes Treatment Market Size by Type (2015-2020) (US$ Million)
Table 37. Europe Diabetes Treatment Market Share by Type (2015-2020)
Table 38. Europe Diabetes Treatment Market Size by Application (2015-2020) (US$ Million)
Table 39. Europe Diabetes Treatment Market Share by Application (2015-2020)
Table 40. Europe Diabetes Treatment Market Size by Country (US$ Million) (2015-2020)
Table 41. Europe Diabetes Treatment Market Share by Country (2015-2020)
Table 42. China Diabetes Treatment Market Size by Type (2015-2020) (US$ Million)
Table 43. China Diabetes Treatment Market Share by Type (2015-2020)
Table 44. China Diabetes Treatment Market Size by Application (2015-2020) (US$ Million)
Table 45. China Diabetes Treatment Market Share by Application (2015-2020)
Table 46. China Diabetes Treatment Market Size by Region (US$ Million) (2015-2020)
Table 47. China Diabetes Treatment Market Share by Region (2015-2020)
Table 48. Japan Diabetes Treatment Market Size by Type (2015-2020) (US$ Million)
Table 49. Japan Diabetes Treatment Market Share by Type (2015-2020)
Table 50. Japan Diabetes Treatment Market Size by Application (2015-2020) (US$ Million)
Table 51. Japan Diabetes Treatment Market Share by Application (2015-2020)
Table 52. Japan Diabetes Treatment Market Size by Country (US$ Million) (2015-2020)
Table 53. Japan Diabetes Treatment Market Share by Country (2015-2020)
Table 54. Southeast Asia Diabetes Treatment Market Size by Type (2015-2020) (US$ Million)
Table 55. Southeast Asia Diabetes Treatment Market Share by Type (2015-2020)
Table 56. Southeast Asia Diabetes Treatment Market Size by Application (2015-2020) (US$ Million)
Table 57. Southeast Asia Diabetes Treatment Market Share by Application (2015-2020)
Table 58. Southeast Asia Diabetes Treatment Market Size by Country (US$ Million) (2015-2020)
Table 59. Southeast Asia Diabetes Treatment Market Share by Country (2015-2020)
Table 60. Novo Nordisk Company Details
Table 61. Novo Nordisk Business Overview
Table 62. Novo Nordisk Product
Table 63. Novo Nordisk Revenue in Diabetes Treatment Business (2015-2020) (US$ Million)
Table 64. Novo Nordisk Recent Development
Table 65. Bayer Company Details
Table 66. Bayer Business Overview
Table 67. Bayer Product
Table 68. Bayer Revenue in Diabetes Treatment Business (2015-2020) (US$ Million)
Table 69. Bayer Recent Development
Table 70. Teva Pharmaceuticals Company Details
Table 71. Teva Pharmaceuticals Business Overview
Table 72. Teva Pharmaceuticals Product
Table 73. Teva Pharmaceuticals Revenue in Diabetes Treatment Business (2015-2020) (US$ Million)
Table 74. Teva Pharmaceuticals Recent Development
Table 75. Merck?Company Company Details
Table 76. Merck?Company Business Overview
Table 77. Merck?Company Product
Table 78. Merck?Company Revenue in Diabetes Treatment Business (2015-2020) (US$ Million)
Table 79. Merck?Company Recent Development
Table 80. Medtronic Company Details
Table 81. Medtronic Business Overview
Table 82. Medtronic Product
Table 83. Medtronic Revenue in Diabetes Treatment Business (2015-2020) (US$ Million)
Table 84. Medtronic Recent Development
Table 85. Johnson?Johnson Company Details
Table 86. Johnson?Johnson Business Overview
Table 87. Johnson?Johnson Product
Table 88. Johnson?Johnson Revenue in Diabetes Treatment Business (2015-2020) (US$ Million)
Table 89. Johnson?Johnson Recent Development
Table 90. Home Diagnostics Company Details
Table 91. Home Diagnostics Business Overview
Table 92. Home Diagnostics Product
Table 93. Home Diagnostics Revenue in Diabetes Treatment Business (2015-2020) (US$ Million)
Table 94. Home Diagnostics Recent Development
Table 95. Amylin Pharmaceuticals Business Overview
Table 96. Amylin Pharmaceuticals Product
Table 97. Amylin Pharmaceuticals Company Details
Table 98. Amylin Pharmaceuticals Revenue in Diabetes Treatment Business (2015-2020) (US$ Million)
Table 99. Amylin Pharmaceuticals Recent Development
Table 100. Abbott Laboratories Company Details
Table 101. Abbott Laboratories Business Overview
Table 102. Abbott Laboratories Product
Table 103. Abbott Laboratories Revenue in Diabetes Treatment Business (2015-2020) (US$ Million)
Table 104. Abbott Laboratories Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Diabetes Treatment Market Share by Type: 2020 VS 2026
Figure 2. Insulin Features
Figure 3. Oral Hypoglycaemic Drugs Features
Figure 4. Non-Insulin Injectable Drugs Features
Figure 5. Others Features
Figure 6. Global Diabetes Treatment Market Share by Application: 2020 VS 2026
Figure 7. Hospital Case Studies
Figure 8. Personal Use Case Studies
Figure 9. Clinic Case Studies
Figure 10. Diabetes Treatment Report Years Considered
Figure 11. Global Diabetes Treatment Market Size (US$ Million), YoY Growth 2015-2026
Figure 12. Global Diabetes Treatment Market Share by Regions: 2020 VS 2026
Figure 13. Global Diabetes Treatment Market Share by Regions (2021-2026)
Figure 14. Global Diabetes Treatment Market Share by Players in 2019
Figure 15. Global Top Diabetes Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetes Treatment as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Diabetes Treatment Revenue in 2019
Figure 17. North America Diabetes Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. United States Diabetes Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Canada Diabetes Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Europe Diabetes Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. Germany Diabetes Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. France Diabetes Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. U.K. Diabetes Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Italy Diabetes Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Russia Diabetes Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Nordic Diabetes Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Rest of Europe Diabetes Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Asia-Pacific Diabetes Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. China Diabetes Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Japan Diabetes Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. South Korea Diabetes Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Southeast Asia Diabetes Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. India Diabetes Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Australia Diabetes Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Rest of Asia-Pacific Diabetes Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Latin America Diabetes Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Mexico Diabetes Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Brazil Diabetes Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Middle East & Africa Diabetes Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Turkey Diabetes Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Saudi Arabia Diabetes Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. UAE Diabetes Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Rest of Middle East & Africa Diabetes Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. Novo Nordisk Revenue Growth Rate in Diabetes Treatment Business (2015-2020)
Figure 45. Bayer Revenue Growth Rate in Diabetes Treatment Business (2015-2020)
Figure 46. Teva Pharmaceuticals Revenue Growth Rate in Diabetes Treatment Business (2015-2020)
Figure 47. Merck?Company Revenue Growth Rate in Diabetes Treatment Business (2015-2020)
Figure 48. Medtronic Revenue Growth Rate in Diabetes Treatment Business (2015-2020)
Figure 49. Johnson?Johnson Revenue Growth Rate in Diabetes Treatment Business (2015-2020)
Figure 50. Home Diagnostics Revenue Growth Rate in Diabetes Treatment Business (2015-2020)
Figure 51. Amylin Pharmaceuticals Revenue Growth Rate in Diabetes Treatment Business (2015-2020)
Figure 52. Abbott Laboratories Revenue Growth Rate in Diabetes Treatment Business (2015-2020)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed